Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
作者信息
Yim Hyung Joon
机构信息
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical College, Ansan, Korea.
出版信息
Clin Mol Hepatol. 2016 Jun;22(2):238-40. doi: 10.3350/cmh.2016.0103. Epub 2016 Jun 30.
Abstract
摘要
相似文献
1
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Clin Mol Hepatol. 2016 Jun;22(2):238-40. doi: 10.3350/cmh.2016.0103. Epub 2016 Jun 30.
2
[The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):387-8.
3
Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
J Hepatol. 2013 Oct;59(4):684-95. doi: 10.1016/j.jhep.2013.05.038. Epub 2013 Jun 3.
4
Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
J Med Virol. 2015 Jun;87(6):1013-21. doi: 10.1002/jmv.24153. Epub 2015 Feb 25.
5
Tenofovir lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.
World J Gastroenterol. 2017 Nov 7;23(41):7459-7469. doi: 10.3748/wjg.v23.i41.7459.
6
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878.
7
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study).
Clin Mol Hepatol. 2016 Dec;22(4):443-449. doi: 10.3350/cmh.2016.0037. Epub 2016 Nov 25.
8
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.
J Hepatol. 2014 Apr;60(4):715-22. doi: 10.1016/j.jhep.2013.11.024. Epub 2013 Dec 1.
9
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
Gastroenterology. 2014 Apr;146(4):980-8. doi: 10.1053/j.gastro.2013.12.028. Epub 2013 Dec 22.
10
Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.
Clin Ther. 2015 Jul 1;37(7):1433-42. doi: 10.1016/j.clinthera.2015.04.007. Epub 2015 May 5.
本文引用的文献
1
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy.
Clin Mol Hepatol. 2016 Jun;22(2):241-9. doi: 10.3350/cmh.2015.0053. Epub 2016 Jun 15.
2
Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study.
Liver Int. 2016 Aug;36(8):1108-15. doi: 10.1111/liv.13059. Epub 2016 Feb 7.
3
Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B.
J Med Virol. 2016 Jun;88(6):1027-34. doi: 10.1002/jmv.24427. Epub 2015 Nov 19.
4
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
Clin Mol Hepatol. 2015 Sep;21(3):242-8. doi: 10.3350/cmh.2015.21.3.242. Epub 2015 Sep 30.
5
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.
Gastroenterology. 2016 Jan;150(1):134-144.e10. doi: 10.1053/j.gastro.2015.09.043. Epub 2015 Oct 8.
6
Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir.
J Gastroenterol Hepatol. 2015 Oct;30(10):1514-21. doi: 10.1111/jgh.12993.
7
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
Gut. 2016 Jun;65(6):1042-51. doi: 10.1136/gutjnl-2014-308435. Epub 2015 Mar 23.
8
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.
Gut. 2016 May;65(5):852-60. doi: 10.1136/gutjnl-2014-308353. Epub 2015 Jan 16.
9
Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.
Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30.
10
Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains.
Antimicrob Agents Chemother. 2014 Nov;58(11):6710-6. doi: 10.1128/AAC.03845-14. Epub 2014 Aug 25.
Zotero 插件